Cartherics raises over $15 million in private financing round

October 1, 2024 Australian Biotech

This is a preview of subscriber content

Subscribe now to continue reading.

CEO Professor Alan Trounson AO said, “The successful capital raising, in times of scant investment support in biotechnology, is welcome and further supports confidence in the company for the delivery of effective therapies in ovarian cancer and other difficult diseases.” …

Subscribe now to continue reading.

Latest Video

New Stories

The need to honour a strong history while ensuring the future is guided by the 'good guys'
November 17, 2025 - - Latest News
BMS Australia team cycles across Japan, raising nearly $20,000 for Bowel Cancer Australia
November 17, 2025 - - Latest News
Syntara secures positive European opinion for orphan designation of amsulostat in myelofibrosis
November 17, 2025 - - Australian Biotech
Mesoblast appoints Chief Financial Officer as it evolves into fully integrated commercial organisation
November 17, 2025 - - Australian Biotech
Argent BioPharma secures significant financing facility to support strategic expansion
November 17, 2025 - - Australian Biotech
Race Oncology launches new clinical programs in AML and lung cancer
November 17, 2025 - - Australian Biotech
Noxopharm begins daily dosing in second phase of HERACLES trial
November 17, 2025 - - Australian Biotech

Cartherics raises over $15 million in private financing round

This is a preview of subscriber content

Latest Video

Most Read

Biotron reports promising advances in Hepatitis B program as lead candidate shows strong antiviral activity

MSD to acquire Cidara Therapeutics, adding long-acting Influenza antiviral CD388 to its pipeline

PYC Therapeutics reports sustained vision gains in RP11 clinical trial

Time to save the government from itself and its own bad habits on this program

Recce Pharmaceuticals pays tribute to founder and scientific pioneer Dr Graham Melrose

New Stories

The need to honour a strong history while ensuring the future is guided by the 'good guys'

BMS Australia team cycles across Japan, raising nearly $20,000 for Bowel Cancer Australia

Syntara secures positive European opinion for orphan designation of amsulostat in myelofibrosis

Mesoblast appoints Chief Financial Officer as it evolves into fully integrated commercial organisation

Argent BioPharma secures significant financing facility to support strategic expansion

Race Oncology launches new clinical programs in AML and lung cancer

Noxopharm begins daily dosing in second phase of HERACLES trial

Sign In

Cartherics raises over $15 million in private financing round

This is a preview of subscriber content

Latest Video

Most Read

Biotron reports promising advances in Hepatitis B program as lead candidate shows strong antiviral activity

MSD to acquire Cidara Therapeutics, adding long-acting Influenza antiviral CD388 to its pipeline

PYC Therapeutics reports sustained vision gains in RP11 clinical trial

Time to save the government from itself and its own bad habits on this program

Recce Pharmaceuticals pays tribute to founder and scientific pioneer Dr Graham Melrose

Follow Us

New Stories

The need to honour a strong history while ensuring the future is guided by the 'good guys'

BMS Australia team cycles across Japan, raising nearly $20,000 for Bowel Cancer Australia

Syntara secures positive European opinion for orphan designation of amsulostat in myelofibrosis

Mesoblast appoints Chief Financial Officer as it evolves into fully integrated commercial organisation

Argent BioPharma secures significant financing facility to support strategic expansion

Race Oncology launches new clinical programs in AML and lung cancer

Noxopharm begins daily dosing in second phase of HERACLES trial